New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - adrenaline acid tartrate 1.8 mg/ml equivalent to 1 mg/ml adrenaline;   - solution for injection - 1 mg/ml - active: adrenaline acid tartrate 1.8 mg/ml equivalent to 1 mg/ml adrenaline   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base;   - concentrate for injection - 1 mg/ml - active: noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base   excipient: nitrogen sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusions and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

New Zealand - English - Medsafe (Medicines Safety Authority)

de healthcare limited - adrenaline acid tartrate 0.018 mg/ml equivalent to adrenaline (epinephrine) base 0.01 mg/ml;  ;  ; articaine hydrochloride 40 mg/ml - solution for injection - 40mg/ml 0.01 mg/ml - active: adrenaline acid tartrate 0.018 mg/ml equivalent to adrenaline (epinephrine) base 0.01 mg/ml     articaine hydrochloride 40 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - ardanest 4% with adrenaline (epinephrine) 1:100,000 and ardanest 4% with adrenaline (epinephrine) 1:200,000 are indicated for infiltration anaesthesia and nerve block anaesthesia in dentistry. ardanest 4% with adrenaline (epinephrine) 1:100,000 is especially indicated for more complex dental procedures requiring prolonged anaesthesia.

New Zealand - English - Medsafe (Medicines Safety Authority)

de healthcare limited - adrenaline acid tartrate 0.009 mg/ml equivalent to adrenaline (epinephrine) base 0.005 mg/ml;  ;  ; articaine hydrochloride 40 mg/ml - solution for injection - 40mg/ml 0.005mg/ml - active: adrenaline acid tartrate 0.009 mg/ml equivalent to adrenaline (epinephrine) base 0.005 mg/ml     articaine hydrochloride 40 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - ardanest 4% with adrenaline (epinephrine) 1:100,000 and ardanest 4% with adrenaline (epinephrine) 1:200,000 are indicated for infiltration anaesthesia and nerve block anaesthesia in dentistry. ardanest 4% with adrenaline (epinephrine) 1:100,000 is especially indicated for more complex dental procedures requiring prolonged anaesthesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 8 mg/ml (equivalent: noradrenaline (norepinephrine), qty 4 mg/ml) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1.8 mg/ml;   - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

Malta - English - Medicines Authority

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - noradrenaline acid, tartrate - concentrate for solution for infusion - noradrenaline acid tartrate 2 mg/ml - cardiac therapy

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline - solution for injection - 1:10000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - adrenaline acid tartrate 18.2 µg/ml equivalent to adrenaline 10 micrograms/ml; articaine hydrochloride 40 mg/ml - solution for injection - active: adrenaline acid tartrate 18.2 µg/ml equivalent to adrenaline 10 micrograms/ml articaine hydrochloride 40 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. indicated only for dental procedures.